Scholarly article on 3-(2-benzoyl-1-cyano-1,2-dihydro-[1]isoquinolylmethyl)-indole-2-carboxylic acid ethyl ester 855645-35-1 from Journal of the American Chemical Society p. 2134,2137

DOI: 10.1021/ja01161a075

Source and publish data:

Journal of the American Chemical Society p. 2134,2137 (1950)

Update date:2022-08-02

Topics:

Authors:

Boekelheide

Ainsworth

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01161a075

Full text of DOI:10.1021/ja01161a075

Products guided by the article

Product name:3-(2-benzoyl-1-cyano-1,2-dihydro-[1]isoquinolylmethyl)-indole-2-carboxylic acid ethyl ester

Cas No:855645-35-1

R&D Labs maybe for 855645-35-1

Shanghai Forever Synthesis Co.,Ltd.

Contact:021-61124658

Address:Zhoukang Road,Pudong New District,Shanghai,China
QINGDAO DEVELOP chemistry Co.,Limited

Contact:+86-532-85807910

Address:98#Nanjing Road, Qingdao, China 266071
Nanjing distinctions Medical Technology Co., Ltd.(expird)

Contact:+86-15996203785 13914714059

Address:nanjing,jiangsu , China
NEW FORTUNE INDUSTRIAL CO.,LTD.

website:http://newfortune.lookchem.com/

Contact:+86-25-8645-9456

Address:C4-105 GREEN ISLAND FLOWER TOWN
Shandong Jiulong Hisince Pharmaceutical Co.,Ltd.

Contact:--

Address:Huadian Pioneer Park, Huadian Township, Qihe County, Dezhou City, Shandong, P.R.China

Relevant to this article

Doi:10.1021/ja01227a035
(1945)
Sweetness of Hesperetin Dihydrochalcone Derivatives Linked to ω-Amino Acid or Its Oligomer

Doi:10.1246/bcsj.56.347
(1983)
PREPARATION OF TERTIARY ARSINE SULPHIDES. CRYSTAL AND MOLECULAR STRUCTURES OF THE ADDUCT OF AsMePh2S AND P(NMe2)3O

Doi:10.1039/DT9810001459
(1981)
ASYMMETRIC SYNTHESIS OF AMINO ACIDS BY CATALYTIC REDUCTION OF AZALACTONES OF SUBSTITUTED ACYLAMINOACRYLIC ACIDS. COMMUNICATION 10. INFLUENCE OF SOLVENT ON REACTION MECHANISM IN REDUCTIVE AMINOLYSIS OF 4-ISOPROPYLIDENE-5-OXAZOLONE

Doi:10.1007/BF01167759
(1983)
Doi:10.1021/ja01316a043
(1934)
Discovery of a Slow Tight Binding LPA1 Antagonist (ONO-0300302) for the Treatment of Benign Prostatic Hyperplasia

Doi:10.1021/acsmedchemlett.7b00383
(2017)

Article Doi

DOI: 10.1021/ja01161a075